Graves' Disease in a Newborn (Neonatal Graves' Disease) - oneGRAVESvoice

Trusted Resources: Evidence & Education

Scientific literature and patient education texts

Back to Evidence & Education / Patient Education

Graves’ Disease in a Newborn (Neonatal Graves’ Disease)

key information

source: University of Rochester Medical Center

year: N/A

summary/abstract:

What is Graves Disease in a Newborn?
Graves disease is an autoimmune disease. The immune system normally protects the body from germs with chemicals called antibodies. But with an autoimmune disease, it makes antibodies that attack the body’s own tissues. With Graves disease, antibodies cause the thyroid gland to make too much thyroid hormone. This is known as hyperthyroidism. Extra thyroid hormone in the bloodstream leads to the body’s metabolism being too active. It can cause problems such as low weight, fast heartbeat, high blood pressure, and heart failure.

Graves disease occurs more often in children than in newborns. But it can also occur in newborn babies. If not diagnosed shortly after birth, Graves disease can be fatal to a newborn baby.

What Causes Graves Disease in a Newborn?
Graves disease in a newborn occurs when the mother has or had Graves disease. The mother’s antibodies can cross the placenta and affect the thyroid gland in the growing baby. Graves disease in a pregnant woman can result in stillbirth, miscarriage, or preterm birth.

 

read more

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close